PT  - JOURNAL ARTICLE
AU  - Malik, N
AU  - Hanna, L
AU  - Harris, L
AU  - Hudson, E
AU  - Burton, S
AU  - Maurice, M
AU  - Green, J
AU  - Turner, J
AU  - Ludlow, H
TI  - EP1106 Evaluation of a late gastrointestinal effects of radiotherapy clinical nurse specialist attending a gynaecological oncology follow-up clinic
AID  - 10.1136/ijgc-2019-ESGO.1148
DP  - 2019 Nov 01
TA  - International Journal of Gynecologic Cancer
PG  - A578--A578
VI  - 29
IP  - Suppl 4
4099  - http://ijgc.bmj.com/content/29/Suppl_4/A578.1.short
4100  - http://ijgc.bmj.com/content/29/Suppl_4/A578.1.full
SO  - Int J Gynecol Cancer2019 Nov 01; 29
AB  - Introduction/Background Patients who receive pelvic radiotherapy may develop gastrointestinal (GI) symptoms which impact on their quality of life (QoL). A GI Specialist Nurse (CNS) has attended our gynaecological follow up clinic since January 2018. This is a new service in addition to a Late GI Effects Clinic based in the local Gastroenterology Department.Methodology From January 2018 to March 2019, 185 patients had received pelvic radiotherapy. 35% (65) of patients with GI symptoms were identified using the ALERT-B (Taylor et al 2016), a quick and simple screening tool. Those who answered yes to any question were seen by the GI CNS and investigated using the ‘Guidance: The Practical Management of Gastrointestinal Symptoms of Pelvic Radiation Disease’ (Andreyev et al 2014).Results Some of the 65 patients had also previously been investigated in the main Late Effects Clinic. The most common findings are shown in table 1 below. Many patients reported more than one symptom.Table 2 below shows the most common abnormal investigation resultsIt was also identified that 22% (14) of patients required specialist dietary advice including certain carbohydrate avoidance, low fat and/or a low FODMAP diet.Conclusion Late GI effects are not uncommon following pelvic radiotherapy and can have a significant impact on the patients QoL. A GI Late Effects CNS in a gynaeoncology follow-up clinic quickly identifies, investigates and treats affected patients thus avoiding further clinic referral and speeding up the patients recovery.Disclosure Nothing to discloseView this table:Abstract EP1106 Table 1 View this table:Abstract EP1106 Table 2